Back to Gene
ROR2 gene
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Gene

ROR2 gene

The ROR2 gene provides instructions for a receptor protein that regulates critical signaling pathways involved in skeletal, heart, and genital development.

Normal Function

The ROR2 gene provides instructions for making a protein that is part of a family known as receptor tyrosine kinases (RTKs). RTKs play a role in chemical signaling within cells, influencing functions such as cell growth and division (proliferation), maturation (differentiation), survival, and movement (motility).

The ROR2 protein is involved in Wnt signaling pathways, which control gene activity and regulate interactions between cells during the formation of organs and tissues. ROR2 appears to be critical for the normal formation of the skeleton, heart, and genitals.

Health Conditions Related to Genetic Changes

Robinow syndrome

At least 20 mutations in the ROR2 gene have been found to cause the autosomal recessive form of Robinow syndrome, a condition affecting the development of many body parts, particularly the bones. These "loss-of-function" mutations prevent the production of functional ROR2 protein, impairing signaling pathways necessary for the formation of bones in the face, spine, and limbs, as well as contributing to genital abnormalities and heart defects.

Other disorders

More than 10 mutations in the ROR2 gene have been identified in brachydactyly type B1, a condition characterized by abnormally short fingers and toes and malformed or absent nails. Unlike the mutations associated with Robinow syndrome, these are "gain-of-function" mutations that appear to cause the ROR2 protein to be continuously active, though the mechanism by which this disrupts bone development remains unclear.

Other Names for This Gene

  • BDB1
  • brachydactyly type B1 gene
  • neurotrophic tyrosine kinase receptor-related 2 gene
  • NTRKR2
  • receptor tyrosine kinase-like orphan receptor 2
  • ROR2_HUMAN

Frequently Asked Questions

Loss‑of‑function mutations cause Robinow syndrome, leading to under‑developed bones and organ anomalies, while gain‑of‑function mutations result in brachydactyly type B1, characterized mainly by short fingers and toes. Treatment for Robinow focuses on growth and organ support, whereas brachydactyly type B1 may only require monitoring and cosmetic interventions.===
targeted ROR2 gene panel or whole‑exome sequencing is the first step. Once a variant is identified, functional studies or segregation analysis in the family can confirm pathogenicity.
Growth hormone therapy may help with height, but its effectiveness varies. Orthopedic procedures can correct limb deformities, and regular cardiac evaluations (echocardiogram, ECG) are essential to detect and manage heart defects early.
Patients typically have short stature, a distinctive facial appearance (prominent forehead, mid‑facial hypoplasia), and shortened limbs with broad, short hands and feet. Heart defects and genital abnormalities are also common, so a comprehensive physical exam and imaging are advised.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Meyahealth

Ⓒ 2026. All rights reserved by MEYA